ZAGREB (Croatia), October 30 (SeeNews) – Croatian pharmaceuticals distributor Medika Group [ZSE:MDKA-R-A] said on Wednesday its consolidated net profit edged up by an annual 0.8% to 60.9 million kuna ($9.1 million/8.2 million euro) in the first nine months of 2019.
Medika Group’s operating profit amounted to 84.5 million kuna in the January-September period, up 11.9% on the year, the company said in an unaudited nine-month financial report filed with the Zagreb Stock Exchange (ZSE).
The company's consolidated total net revenue rose by an annual 17.2% to 2.7 billion kuna in the first nine months of 2019.
Sales revenue amounted to 2.676 billion kuna in the period under review, up 17.6% year-on-year. Sales on the domestic market contributed 99.8% of the total figure.
Material costs increased by 17.9% on the year to 2.5 billion kuna.
The group's gross margin amounted to 8.46% in the first nine months of 2019, down 0.72 pp year-on-year.
Medika employed 847 people at the end of September.
(1 euro = 7.45690 kuna)